FABP2 Ala54Thr polymorphism and diabetes in Chilean elders

Diabetes Research and Clinical Practice

Volumn 77, Issue 2, 2007, Pages 245-250

  Albala, Cecilia ^a   Villarroel, Ana ^a   Santos, José Luis ^a   Angel, Bárbara ^a   Lera, Lydia ^a   Liberman, Claudio ^b   Sanchez, Hugo ^a   Pérez Bravo, Francisco ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Diabetes; Elders; FABP2 polymorphism

Indexed keywords

AMINO ACID; FATTY ACID BINDING PROTEIN; GENOMIC DNA; GLUCOSE; INSULIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CHILE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALANINE; AMINO ACID SUBSTITUTION; CHILE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DNA; FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RESISTANCE; LEUKOCYTES; MALE; THREONINE;

EID: 34247567829     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.006     Document Type: Article

References (35)

1. Sacchettini J.C., Hauft S.M., van Camp S.L., Cistola D.P., and Gordon J.L. Developmental and structural studies of an intracellular lipid binding protein expressed in the ileal epithelium. J. Biol. Chem. 265 (1990) 19199-19207
2. Baier L.J., Sacchettini J.C., Knowler W.C., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding increased fat oxidation and insulin resistance. J. Clin. Invest. 95 (1995) 1281-1287
3. Mitchell B.D., Kammerer C.M., O'Connell P., et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP-2) in Mexican American. Diabetes 44 (1995) 1046-1053
4. Agren J.J., Vidgren H.M., Valve R.S., Laakso M., and Uusitupa M. Postprandial response of individual fatty acids in subjects homozygous for the threonine or alanine encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am. J. Clin. Nutr. 73 (2001) 31-35
5. Lefevre M., Lovejov J.C., Smith S.R., DeLany J.P., Champagne C., Most M.M., et al. Comparison of the acute response to meals enriched with cis or trans fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 54 (2005) 1652-1658
6. Marin C., Pérez-Jiménez F., Gómez P., Delgado J., Paniagua J.A., Lozano A., et al. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am. J. Clin. Nutr. 82 (2005) 196-200
7. Berthier M.T., Couillard C., Prud'homme D., Nadeau A., Bergeron J., Tremblay A., et al. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes. Res. 9 (2001) 668-675
8. Georgopoulos A., Aras O., and Tsai M.Y. Codon 54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J. Clin. Endocrinol. Metab. 85 (2000) 3155-3160
9. Baier L.J., Bogardus C., and Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding proteins alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271 (1996) 10892-10896
10. Brown M.D., Shuldinger A.R., Ferrell R.E., Weiss E.P., Korytkowski M.T., Zmuda J.M., et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 50 (2001) 1102-1105
11. Galluzzi J.R., Cupples L.A., Meigs J.B., Wilson P.W.F., Schaffer E.J., and Ordovas J.M. Association of the Ala54Thr polymorphism in the intestinal fatty acid-binding protein with 2 h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care 24 (2001) 1161-1166
12. Carlsson M., Orho-Melander M., Hendenbro J., Almgren P., and Groop L. The T54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J. Clin. Endocrinol. Metab. 85 (2000) 2801-2804
13. Albala C., Santos J.L., Cifuentes M., Villarroel A.C., Lera L., Libermann C., et al. Intestinal FABP2 A54T polymorphism: Association with insulin-resistance and obesity in women. Obes. Res. 12 (2004) 340-345
14. Albala C., Lebrao M.L., Leon Diaz E.M., Ham-Chande R., Hennis A.J., Palloni A., et al. The Health, Well-Being, and Aging ("SABE") survey: methodology applied and profile of the study population. Rev. Panam. Salud Pública 17 (2005) 307-322
15. Santos J.L., Albala C., Lera L., Garcia C., Arroyo P., Perez Bravo F., et al. Anthropometric measurements in the elderly population of Santiago, Chile. Nutrition 20 (2004) 452-457
16. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1997, p. 9.
17. Grundy SM, Brewer HI, Cleeman JI, Smith SC, Lenfant C for the Conference Participants. Definition of metabolic syndrome. Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 2004;109:433-38.
18. World Health Organization-International Society of hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999;17:151-83.
19. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: WHO; 1999. Accessed February 3, 2005. http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations. Diabetología 28 (1985) 412-418
21. Instituto Nacional de Estadísticas (INE) Chile 2004. Resultados Oficiales Censo de Población 2002. Santiago, Chile; 2004. http://www.ine.cl.
22. Kim C.H., Yun S.K., Byun D.W., et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia but not with intestinal fatty acid absorption in Korean men. Metabolism 50 (2001) 473-476
23. Yamada K., Yuan X., Ishiyama S., et al. Association between Ala54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40 (1997) 706-710
24. Boullu-Sanchis S., Lepretre F., Hedelin G., et al. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab. 25 (1999) 150-156
25. Chiu K.C., Chuang L.M., and Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC 2 (2001) 7-13
26. Duarte N.L., Colagiuri S., Palu T., Wang X.L., and Wilcken D.E. Obesity, type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab 79 (2003) 183-188
27. Weiss E.P., Brown M.D., Shuldiner A.R., and Hagberg J.M. Fatty acid binding protein 2 gene variants and insulin resistance: gene and gen-environmental interaction effects. Physiol Genomics 10 (2002) 145-570
28. de Luis D.A., Aller R., Izaola O., Sagrado M.G., and Conde R. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann. Nutr. Metab. 50 (2006) 354-360
29. Sipilainen R., Uusitupa M., Heikkinen S., et al. Variants of the human intestinal fatty acid binding protein 2 gene in obese subjects. J. Clin. Endocrinol. Metab. 82 (1997) 2629-2632
30. Yanagisawa Y., Kawabata T., Tanaka O., Kawakami M., Hasegawa K., and Kagawa Y. Improvement in blood lipid levels by dietary sn-1,3-diacylglycerol in young women with variants of lipid transporters 54T-FABP2 and-493-MTP. Biochem. Biophys. Res. Commun. 302 (2003) 743-750
31. Nakanishi S., Yamane K., Kamei N., Okubo M., and Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans. Diabetes Obes. Metab. 6 (2004) 45-49
32. Formanack M.L., and Baier L.J. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 47 (2004) 349-435
33. Li Y., Fisher E., Klapper M., Boeing H., Pfeiffer A., Hampe J., et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm. Metab. Res. 38 (2006) 300-307
34. Damcott C.M., Feingold E., Moffet S.P., Barmada M.M., Marshall J.A., Hamman R.F., et al. Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum. Genet. 112 (2003) 610-616
35. Ministry of Health, National Institute of Statistics. National Health Survey (ENS) 2003. Ministry of Health, 2004.